WPW
REGN icon

Warther Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Warther Private Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-464
Closed -$294K – 70
2025
Q1 		$294K Sell
464
-4,200
-90% -$2.89M 0.1% 52
2024
Q4 		$3.32M Buy
+4,664
New +$3.91M 1.12% 21
2024
Q2 		– Sell
-2,398
Closed -$2.31M – 89
2024
Q1 		$2.31M Sell
2,398
-151
-6% -$144K 1.03% 28
2023
Q4 		$2.24M Sell
2,549
-837
-25% -$689K 1.25% 24
2023
Q3 		$2.79M Buy
3,386
+52
+2% +$40.9K 1.85% 18
2023
Q2 		$2.4M Sell
3,334
-260
-7% -$200K 1.63% 20
2023
Q1 		$2.95M Buy
3,594
+55
+2% +$41.5K 2.25% 14
2022
Q4 		$2.55M Sell
3,539
-142
-4% -$105K 1.91% 18
2022
Q3 		$2.54M Buy
3,681
+1,865
+103% +$1.17M 2.01% 14
2022
Q2 		$1.08M Buy
1,816
+1,367
+304% +$889K 0.79% 46
2022
Q1 		$312K Buy
+449
New +$284K 0.2% 105

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Warther Private Wealth's REGN Position: Q2 2025 in Review

Warther Private Wealth sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 464 shares — an estimated $294K sold.

Warther Private Wealth first reported a position in REGN in Q1 2022 and held it in 11 quarters. The position peaked at $3.32M in Q4 2024. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Warther Private Wealth reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Warther Private Wealth sold 464 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $294K.
  • Warther Private Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2022 and held it in 11 quarters.
  • Warther Private Wealth's Regeneron Pharmaceuticals position peaked at $3.32M in Q4 2024.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Warther Private Wealth's 13F filing for Q2 2025, filed 30 Jul 2025.